Article Information
History
- June 24, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Reza Rasti1,2,3,&,
- Johanna Brännström1,
- Andreas Mårtensson4,
- Ingela Zenk5,
- Jesper Gantelius6,
- Giulia Gaudenzi1,6,
- Helle M. Alvesson1,* and
- Tobias Alfvén1,5,*
- 1Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden
- 2Paediatric Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden
- 3Paediatric Immuno-psychiatry Unit, CAP Research Centre, Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden
- 4Department of Women’s and Children’s Health, International Maternal and Child Health, Uppsala University, Uppsala, Sweden
- 5Sachs’ Children and Youth Hospital, South General Hospital, Stockholm, Sweden
- 6Division of Nanobiotechnology, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden
- ↵&Corresponding author: Dr Reza Rasti MD, Address: Godtemplarvägen 39, 132 49 Saltsjö-Boo, Sweden reza.rasti{at}ki.se
↵* these authors contributed equally
Posted June 24, 2021.
Point-of-care testing in a high-income country paediatric emergency department – a qualitative study in Sweden
